Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

2.92%

$1.59 race oncology ltd

Ann: H1 2023 Preclinical and Clinical Programs Update, page-108

First 108 Last

Share
Profile

Follow
IndexInvestor

8,611 Posts.

1423

10/07/23

12:09

Post #: 68705767
Share
Originally posted by d3outguncom: ↑

I've read the announcement and the above posts and still have some questions - I accept I'm probably the problem:
Cancellation of development of 110 formulation central venous and focus total development on 220 IV formulation. Does this mean all the research to date on efficacy of 110 is wasted and have to start again on 220? This would be backed by the final 2 patients in the Israeli study being recruited to 220 formulation. Doesn't that mean we now need to redo many years of clinical research with IV delivery to get useful data?
Cancellation on research on efficacy of heart protection in conjunction with other cancer treatments, especially breast cancer RAC008, yet the ongoing heart protection studies to be released in Q3. This was touted as a "bonus" value add and big pharma interest attractor. Why cancel an existing test whilst continuing studies?
The saving of $3m from the cancellation of above study to focus on 220. Are RAC so cash concerned that they are having to cancel studies to have cash for new studies?
Interested in your, and other interested RAC holders, thoughts.

Expand

The heart protection trial isn't cancelled.
The cancelled trial is on what happens WITHOUT bisantrene.
RAC Price at posting: $1.34 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

PAT

Patriot Lithium eyeing up Zambia-based Katawaro copper project

OCT

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

LEX

Lefroy boosts near-surface gold resource by 13% to 439Koz

ARV

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan

ARB

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

There are more pages in this discussion • 12 more messages in this thread...

First 108 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.59		Change 0.045(2.92%)		Mkt cap ! $265.8M

Open	High	Low	Value	Volume
$1.60	$1.60	$1.55	$138.7K	88.71K

Buyers (Bids)

No.	Vol.	Price($)
1	1250	$1.58

Sellers (Offers)

Price($)	Vol.	No.
$1.60	2500	1

View Market Depth

No.	Vol.	Price($)
1	1250	1.580
1	1893	1.575
2	16363	1.570
2	10056	1.560
1	5000	1.555

Price($)	Vol.	No.
1.600	2500	1
1.605	5172	1
1.610	311	1
1.615	347	1
1.620	2622	2

Last trade - 12.20pm 10/10/2024 (20 minute delay)

RAC (ASX) Chart

SPONSORED BY